|
M-1540a - Contribution of 1,3-beta-d-glucan (BDG) to the Diagnosis ff Invasive Aspergillosis (IA) (click for details) |
|
|
|
F1-1387 - Single or Repeat Oral Doses of the Novel CYP51 Inhibitor VT-1161 Suppress Fungal Growth and Provide a Survival Benefit in a Murine Candida glabrata Infection Model (click for details) |
|
|
|
M-307 - Effects of Cefepime (CEF) and Ciprofloxacin (CIP) Alone and in Pair-Wise Combination with Voriconazole (VCZ) and Posaconazole (PCZ) on Monomicrobial (MM) and Polymicrobial (PM) Biofilms of Pseudomonas aeruginosa (Pa) and Aspergillus fumigatus (Af) (click for details) |
|
|
|
M-1523 - In Vitro Evaluation of Immunosuppressants and Antifungals in Combination Against Aspergillus fumigatus (click for details) |
|
|
|
M-1524 - Recursive Partitioning Analysis of CYP51A Mutations for Refinement of Epidemiological Cutoff Values (ECV) of Azoles and A. fumigatus (AF) (click for details) |
|
|
|
F1-1378 - In Vitro Activity of E1210 and In Vivo Activity of E1211: A Water-Soluble Prodrug of E1210 in Combination with Other Antifungals (click for details) |
|
|
|
Title:
M-299 - Proangiogenic Growth Factors Act Synergistically with Amphotericin B (AmB) to Reduce Mortality in Experimental Invasive Pulmonary Aspergillosis (IPA) (click for details) |
|
|
|
Title:
F1-1382 - In Vitro Synergistic Fungicidal Activity of Tricyclazole (TCZ) and Tropolone (TRO) in Combination with Voriconazole (VCZ) against VCZ-Resistant (R) Aspergillus flavus. (click for details) |
|
|
|
M-286 - Early Posaconazole (POS) Prophylaxis During the First 100 Days in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience (click for details) |
|
|
|
A2-584 - Efficacy and Pharmacodynamic of Voriconazole combined with Anidulafungin in azole resistant invasive aspergillosis (click for details) |
|
|
